Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs
about
The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapyDeveloping stem cell therapies for juvenile and adult-onset Huntington's diseaseMesenchymal stem cells: immune evasive, not immune privilegedMesenchymal Stem Cells Yield Transient Improvements in Motor Function in an Infant Rhesus Macaque with Severe Early-Onset Krabbe Disease.Mesenchymal stem cells as cellular vectors for pediatric neurological disordersMesenchymal stem cell therapy of intestinal disease: are their effects systemic or localized?Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins.Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages.Mesenchymal stromal cells in transplantation rejection and tolerance.Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo.Advancing mesenchymal stem/stromal cells-based therapies for neurologic disease.Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine modelMesenchymal stromal cells for tissue-engineered tissue and organ replacements.Mesenchymal stem cells as a treatment for neonatal ischemic brain damage.Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?Regenerative medicine: prospects for the treatment of inflammatory bowel disease.Mesenchymal stem cell priming: fine-tuning adhesion and function.Mesenchymal stromal cells in renal transplantation: opportunities and challenges.Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study.Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis.CD105+-mesenchymal stem cells migrate into osteoarthritis joint: An animal model.Allogeneic transplantation of mobilized dental pulp stem cells with the mismatched dog leukocyte antigen type is safe and efficacious for total pulp regeneration.Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.
P2860
Q26775933-403B2275-2E32-42B8-BCCC-C5DF72C5B0AEQ26799722-40EA0EE4-DC83-4550-985B-F7B66780537BQ27003371-4AB32A52-DB2F-415F-BA8B-409D26C6A616Q33722223-FBFF2393-9795-4304-BDC3-A0DB1BDB6F39Q33918923-90E3F8B7-4565-46D9-B761-682DFFBB2568Q34154534-A6FBA323-0ABB-4AE5-BBAC-2F0127DC50F3Q34292404-0E492D17-C7F0-434F-8242-6833A12C2AADQ36715918-EFA943C0-9133-4F2C-9324-F90FAEFD8D0AQ36786630-DD3768C8-946D-4913-A775-AFA113EDCFD4Q37529754-C61E0D0F-201E-4588-B8DA-B49E8B7A7561Q37655668-2E4E2844-CE80-4D8D-8AB6-6FE0BB3B5C0BQ37671213-65502B07-2D12-4852-A612-EDA28ABD0315Q37976114-B24DC067-0E7B-426B-ADA2-7CE5742773B0Q37995016-2279EB68-C4B7-4B83-846B-E6C57CD7E059Q38064659-4D6AA55A-1EEB-4CB9-8C03-9D924040DFBFQ38133660-71A85892-117A-494D-8C76-357038067284Q38206110-E7B6D15C-ED1E-4B51-9423-6DC7C8030BEAQ38725481-042FB4BC-E83B-4283-9948-98B7FF16EB46Q40235917-C68D2F04-EB1B-4135-818A-ADC3571C2CCFQ45947247-A65CB2FA-FAC6-476F-AFB3-BF9EB8B39A0BQ47099023-4CB129D1-3A25-4E75-96A1-CB82AC1ABF95Q52716159-A10934AD-D315-453E-94CC-F7927E1850E1Q53171235-540DAF4E-92C9-47F6-9290-51B1200D1DED
P2860
Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@ast
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@en
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@nl
type
label
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@ast
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@en
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@nl
prefLabel
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@ast
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@en
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@nl
P2093
P2860
P1476
Cell-dose-dependent increases ...... l injection of allogeneic MSCs
@en
P2093
Calvin Lanclos
Donald G Phinney
Iryna A Isakova
Jason Dufour
Julie Bruhn
P2860
P304
957-967.e1
P356
10.1016/J.EXPHEM.2010.06.011
P577
2010-07-01T00:00:00Z